Mainz Net Debt from 2010 to 2024

MYNZ Stock

USD 0.23 0.02 9.52%

Mainz Biomed Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Mainz Biomed BV minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2010-12-31

Previous Quarter

349.9 K

Current Value

367.3 K

Quarterly Volatility

4.5 M

Credit Downgrade

Yuan Drop

Covid

Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.

Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Net Debt Growth Pattern

Below is the plot of the Net Debt of Mainz Biomed BV over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Mainz Biomed's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Mainz Net Debt Regression Statistics

	Arithmetic Mean	374,108
	Geometric Mean	2,135,208
	Coefficient Of Variation	1,209
	Mean Deviation	2,779,186
	Median	2,210,214
	Standard Deviation	4,524,482
	Sample Variance	20.5T
	Range	16.8M
	R-Value	(0.48)
	Mean Square Error	17T
	R-Squared	0.23
	Significance	0.07
	Slope	(486,379)
	Total Sum of Squares	286.6T

Mainz Net Debt History

	2024	367.3 K
	2023	349.9 K
	2022	-13.9 M
	2021	-6.2 M
	2020	2.9 M

Other Fundumenentals of Mainz Biomed BV

Net Debt To E B I T D A

Mainz Biomed Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Property Plant Equipment	Intangible Assets
Total Assets		0.94	0.93	-0.83	-0.85	0.83	0.72	0.8	0.79	0.99	0.63	0.98	0.87	0.73	0.65	0.87	0.93	-0.83	-0.46
Total Stockholder Equity	0.94		0.93	-0.96	-0.67	0.65	0.72	0.62	0.54	0.97	0.4	0.99	0.65	0.9	0.42	0.65	0.85	-0.69	-0.28
Current Deferred Revenue	0.93	0.93		-0.86	-0.7	0.71	0.9	0.6	0.64	0.94	0.47	0.95	0.76	0.81	0.49	0.76	0.92	-0.77	-0.33
Net Debt	-0.83	-0.96	-0.86		0.43	-0.41	-0.64	-0.38	-0.33	-0.88	-0.12	-0.92	-0.45	-0.99	-0.15	-0.45	-0.68	0.45	0.0
Retained Earnings	-0.85	-0.67	-0.7	0.43		-0.99	-0.57	-0.98	-0.91	-0.8	-0.94	-0.75	-0.94	-0.28	-0.95	-0.94	-0.9	0.96	0.84
Accounts Payable	0.83	0.65	0.71	-0.41	-0.99		0.62	0.96	0.88	0.78	0.95	0.74	0.92	0.27	0.96	0.92	0.92	-0.99	-0.87
Long Term Debt	0.72	0.72	0.9	-0.64	-0.57	0.62		0.41	0.49	0.71	0.42	0.74	0.62	0.61	0.43	0.62	0.86	-0.73	-0.37
Net Receivables	0.8	0.62	0.6	-0.38	-0.98	0.96	0.41		0.87	0.76	0.94	0.7	0.88	0.23	0.95	0.88	0.82	-0.91	-0.84
Total Liab	0.79	0.54	0.64	-0.33	-0.91	0.88	0.49	0.87		0.73	0.85	0.65	0.98	0.2	0.86	0.98	0.78	-0.82	-0.63
Net Invested Capital	0.99	0.97	0.94	-0.88	-0.8	0.78	0.71	0.76	0.73		0.56	0.99	0.81	0.79	0.59	0.81	0.91	-0.78	-0.4
Short Long Term Debt	0.63	0.4	0.47	-0.12	-0.94	0.95	0.42	0.94	0.85	0.56		0.5	0.85	-0.04	1.0	0.85	0.76	-0.91	-0.94
Total Current Assets	0.98	0.99	0.95	-0.92	-0.75	0.74	0.74	0.7	0.65	0.99	0.5		0.75	0.85	0.52	0.75	0.9	-0.76	-0.37
Capital Stock	0.87	0.65	0.76	-0.45	-0.94	0.92	0.62	0.88	0.98	0.81	0.85	0.75		0.32	0.86	1.0	0.88	-0.89	-0.65
Net Working Capital	0.73	0.9	0.81	-0.99	-0.28	0.27	0.61	0.23	0.2	0.79	-0.04	0.85	0.32		-0.01	0.32	0.57	-0.32	0.14
Short Term Debt	0.65	0.42	0.49	-0.15	-0.95	0.96	0.43	0.95	0.86	0.59	1.0	0.52	0.86	-0.01		0.86	0.77	-0.92	-0.94
Common Stock	0.87	0.65	0.76	-0.45	-0.94	0.92	0.62	0.88	0.98	0.81	0.85	0.75	1.0	0.32	0.86		0.88	-0.89	-0.65
Net Tangible Assets	0.93	0.85	0.92	-0.68	-0.9	0.92	0.86	0.82	0.78	0.91	0.76	0.9	0.88	0.57	0.77	0.88		-0.95	-0.67
Property Plant Equipment	-0.83	-0.69	-0.77	0.45	0.96	-0.99	-0.73	-0.91	-0.82	-0.78	-0.91	-0.76	-0.89	-0.32	-0.92	-0.89	-0.95		0.86
Intangible Assets	-0.46	-0.28	-0.33	0.0	0.84	-0.87	-0.37	-0.84	-0.63	-0.4	-0.94	-0.37	-0.65	0.14	-0.94	-0.65	-0.67	0.86

Click cells to compare fundamentals

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	349.9 K	367.3 K
Net Debt To EBITDA	(0.01)	(0.01)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mainz Net Debt from 2010 to 2024

Latest Mainz Biomed's Net Debt Growth Pattern

Mainz Net Debt Regression Statistics

Mainz Net Debt History

Other Fundumenentals of Mainz Biomed BV

Mainz Biomed Net Debt component correlations

About Mainz Biomed Financial Statements

Also Currently Popular

Additional Tools for Mainz Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY